tiprankstipranks
Calidi Biotherapeutics (CLDI)
:CLDI
US Market

Calidi Biotherapeutics (CLDI) Ownership - Who Owns Calidi Biotherapeutics?

Compare
212 Followers

Calidi Biotherapeutics (CLDI) Ownership Overview

4.46%0.24%1.71%0.24%93.36%
1.71% Other Institutional Investors
0.24% ETFs
93.36% Public Companies and Individual Investors
The ownership structure of Calidi Biotherapeutics (CLDI) stock is a mix of institutional, retail, and individual investors. Approximately 2.18% of the company’s stock is owned by Institutional Investors, 4.46% is owned by Insiders, and 93.36% is owned by Public Companies and Individual Investors.
The ownership structure of Calidi Biotherapeutics (CLDI) stock is a mix of institutional, retail, and individual investors. Approximately 1.95% of the company’s stock is owned by Institutional Investors, 4.46% is owned by Insiders, and 0.24% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$14376

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
992,094Insider3.83%1,339,327
94,697Institution0.37%127,841
67,774Insider0.26%91,495
66,712Insider0.26%90,061
61,374Institution0.24%82,855
48,574Institution0.19%65,575
28,976Insider0.11%39,118
12,501Institution0.05%16,876
10,000Institution0.04%13,500
2,435Institution<0.01%3,287

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
48,574Institution0.19%65,575
10,000Institution0.04%13,500
2,435Institution<0.01%3,287
1,494Institution<0.01%2,017

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
61,374Institution0.24%70,580

FAQ

Who Owns Calidi Biotherapeutics (CLDI)?
According to the latest TipRanks data, approximately 1.71% of the company's stock is held by institutional investors, 4.46% is held by insiders, and 93.36% is held by retail investors.
    What percentage of Calidi Biotherapeutics (CLDI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.71% of Calidi Biotherapeutics (CLDI) stock is held by institutional investors.
      What percentage of Calidi Biotherapeutics (CLDI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 93.36% of Calidi Biotherapeutics (CLDI) stock is held by retail investors.
        Who owns the most shares of Calidi Biotherapeutics (CLDI)?
        James Schoeneck owns the most shares of Calidi Biotherapeutics (CLDI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis